Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 946 of 5804
-
Can less frequent bladder cancer checkups be just as safe?
Disease control Not yet recruitingCSP #2036 is a pragmatic, randomized, intent-to-treat, two-arm, parallel, multicenter CSP trial. Blinding of clinical staff and participants will not be possible. However, outcomes will be adjudicated by assessors blinded to randomization arm to minimize bias. Due to the pragmati…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Glowing dye could prevent bile duct injuries in emergency gallbladder surgery
Symptom relief Not yet recruitingAcute cholecystitis is a common indication for emergency laparoscopic cholecystectomy. Inflammatory changes and distorted anatomy may increase the risk of biliary complications, including bile duct injury and bile leak, which are associated with significant morbidity, reintervent…
Phase: NA • Sponsor: Hospital del Mar • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
Genetically modified cells injected into mouth lesions to stop cancer before it starts
Disease control Not yet recruitingThis is a phase 1, single-arm, open-label, dose-escalation and dose-expansion study designed to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary efficacy of TGFBR2 TROP2 CAR/IL15 NK cells in patients with high-risk oral premalignant lesions.
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Can cholesterol drugs shield the heart during melanoma immunotherapy?
Disease control Not yet recruitingImmune checkpoint inhibitors (ICIs) are a class of medications that are now standard in the treatment of melanoma. These are standard therapy for melanoma, but long-term side effects on disease in the heart arteries is poorly understood. In this study, melanoma patients receiving…
Phase: NA • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Can stem cells save dying hip bones? new study halted
Disease control TerminatedThe purposes of the study is to evaluate the safety and efficacy of human umbilical cord mesenchymal stem cells (hUC-MSC) in treating osteonecrosis of femoral head patients.
Phase: PHASE1, PHASE2 • Sponsor: Sclnow Biotechnology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Could an antidepressant ease chronic bladder pain? new trial investigates
Symptom relief Not yet recruitingThis study aims to compare two treatment plans for adults with bladder pain syndrome (also called interstitial cystitis), a disease that causes long-lasting bladder pain, frequent urination and urgent need to pee. All participants will receive standardized patient education and b…
Phase: PHASE1 • Sponsor: Beijing Tiantan Hospital • Aim: Symptom relief
Last updated Jul 15, 2026 00:00 UTC
-
Head-to-Head: which drug combo tames psoriatic arthritis better?
Disease control Not yet recruitingThe aim of this work is to compare the efficacy of Apremilast combined with Methotrexate versus Adalimumab combined with Methotrexate
Phase: NA • Sponsor: Tanta University • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Smart alerts aim to slash stroke risk in heart patients
Prevention Not yet recruitingAtrial fibrillation (AF) is the most preventable cause of stroke. However, despite widely available risk stratification tools, numerous options for oral anticoagulation, and evidence-based practice guidelines, anticoagulation for stroke prevention in AF is consistently under-pres…
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Prevention
Last updated Jun 27, 2026 09:08 UTC
-
New shoulder implant aims to cut Re-Tear rates after rotator cuff surgery
Disease control TerminatedThe study design is a prospective, multi-center, single-arm, non-randomized, and noncontrolled post market clinical follow-up study involving orthopedic surgeons skilled in arthroscopic rotator cuff repair as determined by the Sponsor.
Sponsor: Zimmer Biomet • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Freeze away stomach bleeding: new spray trial offers hope
Disease control Recruiting nowThe purpose of this study is to evaluate the impact of cryotherapy spray treatment for eradication of gastric antral vascular ectasia by measuring the change in hemoglobin levels and transfusion requirements in the first 6 months of cryotherapy treatment compared to the previous …
Phase: NA • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Experimental combo aims to tackle stubborn colorectal cancer
Disease control Recruiting nowThis phase I/II trial studies the side effects and best dose of pidnarulex when given together with cemiplimab and to see how well it works in treating patients with microsatellite stable (MSS) colorectal cancer (CRC) that does not respond to treatment (refractory). Pidnarulex ma…
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
New drug aims to keep leukemia in remission after transplant
Disease control Recruiting nowThis phase I trial tests the safety, side effects and best dose of asciminib as maintenance treatment for adults with Philadelphia chromosome positive acute lymphoblastic leukemia (ALL) who have undergone cellular therapies such as hematopoietic stem cell transplantation (HSCT) o…
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug duo targets hard-to-treat lymphoma
Disease control Not yet recruitingThis phase II trial tests the effect of nemtabrutinib in combination with rituximab in treating patients with marginal zone lymphoma. Nemtabrutinib, a non-covalent Bruton's tyrosine kinase (BTK) inhibitor, may stop the growth of cancer cells by blocking some of the enzymes needed…
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Could a blood injection ease Amputees' nerve pain?
Symptom relief Not yet recruitingPatients with combat-related amputations frequently experience chronic neuroma pain that may interfere with rehabilitation, prosthesis use, mobility, sleep, and quality of life. Current treatment approaches often provide only temporary pain relief. Platelet-rich plasma (PRP) has…
Phase: NA • Sponsor: Ukrainian Society of Regional Anesthesia and Pain Therapy • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
New drug aims to stop Post-Surgery breathing danger
Prevention Not yet recruitingThis study is a Phase II, randomized, placebo-controlled, double-blind trial in 200 subjects having general anesthesia for major elective surgery with postoperative pain management to evaluate the efficacy, safety and tolerability of ENA-001 as a therapy to prevent post operative…
Phase: PHASE2 • Sponsor: Enalare Therapeutics Inc. • Aim: Prevention
Last updated Jun 27, 2026 09:09 UTC
-
Engineered immune cells take aim at Hard-to-Treat leukemia
Disease control Not yet recruitingThis phase I trial studies the side effects and best dose of BSB-2002 when given after cyclophosphamide and fludarabine and tests how well it works in treating NPM1-mutated acute myeloid leukemia (AML) that has come back after a period of improvement (relapsed) or that does not r…
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New drug combo aims to tame aggressive lymphoma in frail patients
Disease control Not yet recruitingThis phase I trial tests the safety, side effects and best dose of epcoritamab alone and epcoritamab with polatuzumab vedotin, rituximab, cyclophosphamide, doxorubicin, and prednisone (pola-R- mini-CHP) for the treatment of diffuse large B cell lymphoma (DLBCL) in elderly or unfi…
Phase: PHASE1 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Could 5 days of radiation replace 25 for sarcoma patients?
Disease control Not yet recruitingThis clinical trial compares the effect of short-course ultrahypofractionated radiation therapy over 5 days (UHRT-5) to standard-course radiation therapy over 25 days (RT-25) in treating patients with soft tissue sarcomas of the extremities that may be primary or that may have co…
Phase: PHASE3 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Could a simple spray prevent dangerous blood pressure spikes after spinal injury?
Prevention Not yet recruitingThis project aims to evaluate the safety and efficacy of using a short-acting drug to reduce the maximal blood pressure during dangerous blood pressure spikes that happen during bowel care in individuals with spinal cord injury. the investigators will monitor the physiological ef…
Phase: PHASE2 • Sponsor: Simon Fraser University • Aim: Prevention
Last updated Jun 27, 2026 12:23 UTC
-
Can less therapy at home match intensive autism treatment?
Disease control Not yet recruitingThe Early Start Denver Model (ESDM) has shown its efficiency in the early management of ASD. The study aims to evaluate the efficiency of a new type of management based on a semi-intensive center-based intervention (8h per week) coupled with a MOOC (Massive Online Open Course: a…
Phase: NA • Sponsor: University Hospital, Brest • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC